Cleveland Clinic Children’s Among First Hospitals to Use Novel Gene Therapy to Treat Inherited Blood Disorders
CASGEVY (exagamglogene autotemcel) is a one-time gene therapy for people with sickle cell disease...
Read MoreCASGEVY (exagamglogene autotemcel) is a one-time gene therapy for people with sickle cell disease...
Read MoreSam Hazen, CEO of HCA Healthcare, and Dr. Anderson Spickard, Dean of the Thomas F. Frist, Jr....
Read MoreMay 19, 2025 – Gregg and Lori Gottsegen recently made a generous $1 million gift to Keeping the...
Read MoreMay 21, 2025 – A study from Lerner Children’s Pavilion at Hospital for Special Surgery (HSS)...
Read MoreNational Trauma Survivor’s Day May 21, 2025 – In observance of National Trauma Survivors Day,...
Read More